Search

Funder: Everts Luff Feline Endowment, Funder: IDEXX Laboratories, Funder: Petplan Charitable Trust; Id: http://dx.doi.org/10.13039/100009449, BACKGROUND: The natural history of hypertrophic cardiomyopathy (HCM) in cats has been mainly studied in cats referred for suspected heart disease, which can skew the results towards cats with clinical signs. Few data are available on factors associated with development of HCM in cats. HYPOTHESES: (1) Clinical variables can predict which cats will develop HCM; (2) HCM in cats not referred for suspected heart disease is associated with a low rate of cardiovascular events. ANIMALS: One hundred seven cats from rehoming centers without a history of clinical signs of cardiac or systemic disease at the time of adoption. METHODS: Prospective longitudinal study. After rehoming, shelter cats were reexamined for serial echocardiograms. Cox regression analysis was used to identify predictors of development of HCM in cats that were normal at baseline. Adverse cardiovascular events including heart failure, thromboembolism, or sudden death were recorded. RESULTS: Cats were monitored for a median of 5.6 [1.2-9.2] years. At baseline, 68/107 cats were normal, 18/107 were equivocal and 21/107 had HCM. Nineteen cats developed HCM during the study period. The factors at baseline associated with increased hazard of developing HCM were lower left atrial fractional shortening, higher left ventricular fractional shortening, and higher body weight. Cardiovascular events were observed in 21% of cats with HCM. CONCLUSIONS AND CLINICAL IMPORTANCE: Cardiovascular events were common in cats with HCM from a rehoming center study sample. Lower left atrial systolic function appears to precede overt HCM.

The basic hypothesis tested in this study was that dogs with dilated cardiomyopathy have abnormal ventricular function, and that this can be detected noninvasively using M-mode, two-dimensional (2D), and Doppler echocardiography, and also by measuring myocardial ultrasonic integrated backscatter. An additional hypothesis was that different breeds of dogs affected with DCM have a different clinical course, and that differences in ventricular function between these breeds can be detected by echocardiography or integrated backscatter measurements that might account for the different prognosis The aims of this study therefore were (1) to identify echocardiographic variables that distinguished normal dogs from dogs with DCM; (2) to identify differences in ventricular function using echocardiography between Dobermanns and English cocker spaniels with DCM; and (3) to measure ultrasonic integrated backscatter in normal dogs and in Dobermanns and Cocker spaniels with DCM. In this group of Dobermanns, median survival time was 98 days (range 16 - 508 days), whereas median survival in the cocker spaniels was 512 days (range 51 to >1388 days), with 6/11 still alive at the time of writing (p < 0.002). All the measured M-mode variables differed significantly between the normal dogs and the dogs with DCM. Compared with the Dobermanns, the cocker spaniels had significantly increased LV free wall thickening and increased LV diastolic diameter when indexed to body surface area. All the 2D echocardiographic variables were significantly different between the normal dogs and dogs with DCM when corrected for body size, but there were no significant differences between Dobermanns and cocker spaniels. Significant differences were found between normal and DCM dogs in some but not all of the Doppler echocardiographic variables. Cocker spaniels had higher mitral A wave velocities than the normal dogs, and decreased mitral E/A ratios compared with both the other groups. Dobermanns had shorter isovolumic relaxation times than the other groups In the second part of this study, measurements were made of ultrasonic integrated backscatter in selected regions of the left ventricle in normal dogs and dogs with DCM. Ultrasonic integrated backscatter is a measurement of the power of the ultrasound signal returned from the myocardium to the transducer. This backscattered signal reflects basic tissue properties, and exhibits dynamic variation with contractile function that may represent fundamental alterations in the shape, size and distribution of scatterers within the myocardium. Consistent cyclic variation in integrated backscatter was observed in the LV free wall and septum of the normal dogs, but this pattern was not consistently seen in the DCM dogs. Differences were not seen between the Dobermanns and cocker spaniels, although the number of cocker spaniels measured was small. In conclusion, the DCM dogs had evidence of markedly reduced systolic function compared with the normal dogs. The affected dogs had left atrial and left ventricular dilation with thinner left ventricular walls. Although there was little evidence of any difference in systolic function between the two affected breeds, there was evidence of different diastolic function, with a tendency for Dobermanns to show a restrictive pattern of transmitral filling, and cocker spaniels to show evidence of delayed relaxation. The different pattern of diastolic dysfunction in the two breeds is consistent with the prognostic value ascribed to transmitral flow patterns in human DCM patients: delayed relaxation patterns have been associated with improved survival times in man. Reduced cyclic variation of ultrasonic integrated backscatter was also seen in the dogs affected with DCM, although no differences were found between the two affected breeds.

BACKGROUND: There is a lack of clinical data on hypertrophic cardiomyopathy (HCM) in dogs. HYPOTHESIS/OBJECTIVES: To investigate signalment, clinical signs, diagnostic findings, and survival in dogs with HCM. ANIMALS: Sixty-eight client-owned dogs. METHODS: Retrospective multicenter study. Medical records were searched between 2003 and 2015. The diagnosis of left ventricular (LV) hypertrophy was made by echocardiographic examination. RESULTS: Three hundred and forty-five dogs with LV hypertrophy were identified, of which 277 were excluded. The remaining 68 dogs were 0.3 to 14 years old and predominantly

Background N‐terminal pro B‐type natriuretic peptide (NT‐proBNP) and cardiac troponin‐I (cTnI) are biomarkers commonly evaluated in cats with suspected heart disease. Many cats with hypertrophic cardiomyopathy (HCM) have systolic anterior motion of the mitral valve (SAM), but its influence on circulating NT‐proBNP or cTnI concentrations is currently unknown. Hypothesis/Objectives Cats with HCM and SAM (HCMSAM+) have higher NT‐proBNP and cTnI concentrations than do cats with HCM but without SAM (HCMSAM−). Animals One hundred forty cats with HCM: 70 with SAM and 70 without SAM. Methods Retrospective case‐to‐case study. Cats were recruited if diagnosed with HCM by echocardiography and results were available for NT‐proBNP or cTnI concentrations or both. Cats with SAM were matched to those without SAM for clinical presentation, left atrial (LA) size and left ventricular (LV) fractional shortening. Results A total of 119 NT‐proBNP and 123 cTnI results were available. The HCMSAM+ cats had higher median concentrations than did HCMSAM− cats for NT‐proBNP (729 pmoL/L; interquartile range [IQR], 275‐1467 versus 65 pmoL/L; IQR, 25‐271; P